Lyndra Therapeutics, a drug developer that spun out of the lab of MIT professor Bob Langer in 2015, is winding down ...

(Reuters) -Danish drugmaker Novo Nordisk has secured the global rights to develop, manufacture and sell China-based United ...

There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...

Danish drugmaker Novo Nordisk has bought global rights to China-based United Laboratories International's so-called "triple-G ...

A new biotech is raising money to develop a drug believed to be capable of starving cancer cells, based on research out of a ...

Novo will license UTB251, a triple hormone receptor agonist that in mid-2023 achieved promising weight reduction in a ...

(Reuters) -Danish drugmaker Novo Nordisk has secured the global rights to develop, manufacture and sell China-based United Laboratories International's weight-loss drug candidate in a deal worth up to ...

Cell therapy biotech bit.bio is slimming its workforce by 25% as the company pivots to focus on biomedical tools instead of ...

The issuer is solely responsible for the content of this announcement.

A Tyneside biotech business is set to launch a recruitment drive after doubling the size of its Newcastle base. HistoCyte Laboratories, which develops medical testing products, has grown to a team of ...